NeuroScientific Biopharma rises on positive results for tissue-repair drug

Neuroscientific Biopharmaceuticals

21/12/2021 03:21

** Drug developer's shares  NSB.AX  rise as much as 6.7% to
A$0.325, on track for sharpest single day pct gain since Dec. 3
    ** Company says a pre-clinical biomarker study shows its
pipeline of candidate peptides, a compound consisting of amino
acids, regulates key inflammatory and immune biomarkers
 urn:newsml:reuters.com:*:nASX3dsX8M
    ** NSB says its peptide-based compound MTIIA helps in
regulating processes of the immune system that stabilises tissue
damage and aids in tissue repair 
    ** Shares hit highest level since Dec. 14
    ** Company's shares up 22% this year, as of last close

 (Reporting by Roushni Nair in Bangalore)
 ((Roushni.Nair@thomsonreuters.com))